Newer Anticoagulants Can Be Used Off-Label

被引：0

作者：

Choi, Philip M. C. ^{[1
]}

Hill, Michael D. ^{[1
]}

机构：

[1] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary Stroke Program, Calgary, AB T2N 2T9, Canada

来源：

关键词：

atrial fibrillation; heart; heart failure; stroke; transient ischemic attack; ATRIAL-FIBRILLATION; WARFARIN; DABIGATRAN; PREVENTION; ASPIRIN;

D O I：

10.1161/STROKEAHA.113.002694

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2154 / 2155

页数：2

共 50 条

[21] The "Off-label" TAVI
Kornowski, Ran
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (08): : 443 - 444
[22] Off-label perils
不详
COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 2004, 26 (11): : 834 - 834
[23] Off-label therapy
Myers, Gary
NEW SCIENTIST, 2014, 223 (2983) : 29 - 29
[24] "Off-label" deworming
Boissevain, Iaira
TIJDSCHRIFT VOOR DIERGENEESKUNDE, 2009, 134 (21) : 897 - 897
[25] Going off-label
Lucas, Catherine
LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08): : 556 - 556
[26] Off-label prescribing
Gazarian, Madlen
Morris, Steve
MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (11) : 637 - 637
[27] Off-label prescribing
Seale, J. Paul
MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (02) : 65 - 65
[28] Off-label prescribing
Kelly, Maria
Gazarian, Madlen
McPhee, John
AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 7 - 7
[29] OFF-LABEL PREEMPTION
Simon, David A.
WISCONSIN LAW REVIEW, 2024, (03) : 1080 - 1147
[30] A status for off-label
Derrien, Elisa
ACTUALITES PHARMACEUTIQUES, 2019, 58 (582): : 6 - 6